Biotech frontierAug. 1, 2001 Charleston Regional Business Journal
By Dennis Quick, Staff Writer “Some analysts estimate tissue engineering to be a potential $400 billion market,” claims Mironov. “The tissue engineering industry could be the most profitable of the 21st century.” And Charleston could become one of the more profitable players, Mironov emphasizes. With tissue engineering companies like Cardiovascular Tissue Technologies Inc. and Organ Recovery Systems Inc. already here, plus MUSC’s ongoing efforts in the field, the Holy City could become a Silicon Valley of biotechnology. |
![]() |